Epoch Investment Partners Inc. grew its stake in shares of Petmed Express Inc (NASDAQ:PETS) by 71.4% in the third quarter, HoldingsChannel reports. The firm owned 857,722 shares of the company’s stock after purchasing an additional 357,304 shares during the period. Epoch Investment Partners Inc.’s holdings in Petmed Express were worth $28,313,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Scout Investments Inc. increased its holdings in Petmed Express by 2.3% during the 3rd quarter. Scout Investments Inc. now owns 82,754 shares of the company’s stock worth $2,732,000 after purchasing an additional 1,878 shares in the last quarter. Virginia Retirement Systems ET AL boosted its stake in shares of Petmed Express by 6.4% in the 2nd quarter. Virginia Retirement Systems ET AL now owns 31,700 shares of the company’s stock worth $1,396,000 after buying an additional 1,900 shares during the last quarter. Alps Advisors Inc. boosted its stake in shares of Petmed Express by 19.5% in the 2nd quarter. Alps Advisors Inc. now owns 12,289 shares of the company’s stock worth $559,000 after buying an additional 2,007 shares during the last quarter. Smith Asset Management Group LP boosted its stake in shares of Petmed Express by 3.5% in the 2nd quarter. Smith Asset Management Group LP now owns 65,939 shares of the company’s stock worth $2,905,000 after buying an additional 2,220 shares during the last quarter. Finally, Legal & General Group Plc boosted its stake in shares of Petmed Express by 7.3% in the 2nd quarter. Legal & General Group Plc now owns 40,808 shares of the company’s stock worth $1,806,000 after buying an additional 2,783 shares during the last quarter. 95.11% of the stock is owned by hedge funds and other institutional investors.

In related news, Director Robert C. Schweitzer sold 7,500 shares of the company’s stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $37.00, for a total value of $277,500.00. Following the transaction, the director now owns 88,334 shares in the company, valued at $3,268,358. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 3.70% of the stock is owned by insiders.

Shares of NASDAQ PETS opened at $22.42 on Friday. Petmed Express Inc has a twelve month low of $22.11 and a twelve month high of $57.80. The company has a market capitalization of $484.18 million, a PE ratio of 11.26 and a beta of 0.79.

Petmed Express (NASDAQ:PETS) last announced its earnings results on Monday, October 22nd. The company reported $0.52 earnings per share for the quarter, topping analysts’ consensus estimates of $0.50 by $0.02. Petmed Express had a return on equity of 35.53% and a net margin of 14.88%. The firm had revenue of $71.40 million for the quarter, compared to the consensus estimate of $71.93 million. During the same quarter in the previous year, the business earned $0.43 EPS. The company’s revenue was up 7.0% compared to the same quarter last year.

The firm also recently announced a quarterly dividend, which was paid on Friday, November 16th. Stockholders of record on Monday, November 5th were paid a $0.27 dividend. The ex-dividend date of this dividend was Friday, November 2nd. This represents a $1.08 dividend on an annualized basis and a dividend yield of 4.82%.

A number of equities analysts have recently weighed in on the company. BidaskClub downgraded Petmed Express from a “hold” rating to a “sell” rating in a research note on Wednesday, October 3rd. ValuEngine upgraded Petmed Express from a “strong sell” rating to a “sell” rating in a research note on Monday, August 20th. Finally, TheStreet downgraded Petmed Express from a “b” rating to a “c+” rating in a research note on Thursday, November 29th. Three research analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the company’s stock. Petmed Express currently has a consensus rating of “Hold” and a consensus target price of $42.67.

COPYRIGHT VIOLATION NOTICE: “Epoch Investment Partners Inc. Buys 357,304 Shares of Petmed Express Inc (PETS)” was first posted by Watch List News and is owned by of Watch List News. If you are viewing this article on another website, it was copied illegally and reposted in violation of United States and international copyright laws. The correct version of this article can be accessed at https://www.watchlistnews.com/epoch-investment-partners-inc-buys-357304-shares-of-petmed-express-inc-pets/2669719.html.

Petmed Express Company Profile

PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.

See Also: Market Capitalization

Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Petmed Express Inc (NASDAQ:PETS).

Institutional Ownership by Quarter for Petmed Express (NASDAQ:PETS)

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.